As prescription drug affordability boards move toward upper payment limit implementation, uncertainties introduced across the health care system and risks to patient access warrant urgent attention.
Online Early
Most surveyed individuals with obesity support lower-cost options for weight maintenance, which would allow better coverage for injectable incretin mimetics for weight management during active weight loss.
Advertisement
Advertisement
Trending on AJMC
1
Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH
2
FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated mHSPC
3
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
4
From Functional to True Hepatitis B Cure: Jordan Feld, MD, MPH
5